{
  "pmcid": "12471133",
  "sha256": "9e8425576c38fde4bee4ae7e68622417be25c0b1711caef33cd867f8bcd8ce17",
  "timestamp_utc": "2025-11-09T23:40:08.226111+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.138913669064749,
    "reading_ease": 39.95959352517988,
    "word_count": 278
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Title: Randomised Controlled Trial of Carbon Nanotubes in Cancer Treatment"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomly assigned to receive either CNT-based treatment or standard care."
      },
      "Participants": {
        "score": 2,
        "evidence": "Participants were patients diagnosed with PC, LC, GC, CRC, or RC, recruited from a clinical setting. Eligibility criteria included confirmed diagnosis and consent to participate."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomly assigned to receive either CNT-based treatment or standard care."
      },
      "Objective": {
        "score": 1,
        "evidence": "Objective: To assess the effectiveness of CNTs in improving treatment outcomes for PC, LC, GC, CRC, and RC."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the improvement in survival rate over a 5-year period."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was performed using a computer-generated sequence, and allocation was concealed using sealed envelopes."
      },
      "Blinding": {
        "score": 3,
        "evidence": "Blinding was applied to outcome assessors, patients, and clinicians."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "A total of 200 participants were randomised, with 100 in the CNT group and 100 in the control group, recruited between January 2020 and June 2021."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on 98 participants in the CNT group and 97 in the control group using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The CNT group showed a significant improvement in survival rate (mean difference = 5.2%, 95% CI 3.1 to 7.3; p = 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were mild, with 3% in the CNT group and 1% in the control group experiencing mild gastrointestinal side-effects."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT01773850."
      },
      "Funding": {
        "score": 0,
        "evidence": "The trial was funded by [source not specified]."
      }
    },
    "total_score": 23,
    "max_score": 25
  }
}